Filter

71 - 80 of 319 Results

  • Mpox One Year Later: Where is the U.S. today?

    Issue Brief

    This brief provides an overview of the impact of mpox in the U.S. one year after a case of was identified domestically and the federal response to date, and discusses the future outlook.

  • Timeline of End Dates for Key Health-Related Flexibilities Provided Through COVID-19 Emergency Declarations, Legislation, and Administrative Actions

    Issue Brief

    In response to the COVID-19 pandemic, the federal government declared numerous types of emergencies, Congress enacted several pieces of legislation, and various executive actions were taken and waivers issued, which established time-limited flexibilities and provisions designed to protect individuals and the health system during the pandemic. This resource provides a timeline identifying key health-related flexibilities and provisions specified by these various measures, the specific measure that determines their end date, and their end date.

  • KFF COVID-19 Vaccine Monitor: March 2023

    Poll Finding

    As the COVID-19 public health emergency comes to an end, about half of adults say they would be likely to get an annual COVID-19 booster. Around one in three adults don't think they have ever had COVID-19, nor have they ever tested positive for it, and they primarily attribute this to taking precautions such as avoiding crowds.

  • How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization?

    Issue Brief

    This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for the COVID-19 bivalent boosters to the estimated average commercial prices across different scenarios.

  • KFF COVID-19 Vaccine Monitor: January 2023

    Feature

    This survey finds that nearly four-in-ten adults say their households were recently sick with COVID-19, the Flu, or RSV, and news of the viruses is making many more likely to wear masks and take other precautions. It also explores uptake of the new bivalent booster, why many vaccinated adults have not gotten it, and enthusiasm for another shot among those who have.

  • Nearly Four in Ten Say Their Households Were Sick with COVID-19, the Flu, or RSV Recently Even as Most People Say They Aren’t Too Worried About Getting Seriously Ill

    News Release

    Booster update remains modest; half of those already boosted are waiting for updated CDC guidelines to get another dose Nearly four in ten (38%) people say their households were affected by this winter's triple threat of viruses, with someone getting sick with the flu, COVID-19, or respiratory syncytial virus (RSV), and nearly half (46%) say…